Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer
This page documents how this source is reused across Claim by Claim. A source can support, challenge, qualify or contextualize different claims; appearing here does not imply endorsement of every linked proposition.
Evidence roles describe what this source helps establish inside each Investigation. They are local to that use, not permanent labels attached to the publication itself.
A 2023 reanalysis of the original Aykut human pancreatic sequencing dataset failed to reproduce the cancer-associated fungal signal; the original study authors published a counteranalysis disputing the bioinformatic pipeline. These share original patient sequences, not independently recruited cohorts.